We demonstrated that AGN inhibits cell viability in three DLBCL cell lines (Ly1, Ly10, and DHL6) through the activation of caspase 3/7 by downregulating PI3K/AKT/mTOR and MAPK pathways (Figs 1 and 2). Here, AKT1 is linked to diffuse large B-cell lymphoma.